About us
Inside mAIbe and Our Values
✦ Biotechnology Startup
Powered by
advanced artificial intelligence
We are an innovative biotechnology startup which leverages advanced, Physics-informed Artificial Intelligence. Our core objective is the research, development, and production of anti-infective medicinal products using cutting-edge machine learning, physics-informed generative AI, and synthetic biology.
Our team is developing a data- and model- driven platform specifically engineered for precise monoclonal antibody (mAb) design. This innovative approach aims to reduce manufacturing costs, enhance accessibility to wider populations, and broaden the applications of monoclonal antibodies in combating infectious diseases.
Traditionally, mAbs have primarily targeted oncology and autoimmune disorders. However, the global threat of infectious diseases demands accelerated innovation in this area. As a result, our research prioritizes monoclonal antibody solutions specifically designed to prevent or mitigate current and emerging pandemics.
Our Values
#BelieveInASaferWorld
We believe in relentless methodological and technological innovation to make our world safer
#AIDemocratizeDrugs
We use AI to democratize the next generation of medical treatments
#AccessibleTherapies
We envision a world where access to new therapies is universally available
#ReduceAnimalTesting
We uphold the principle of 3R (Reduce, Refine, Replace) in minimizing animal testing
#Multidisciplinary
Our success stems from a multidisciplinary team that highly values diverse expertise
#ScientificNetwork
We promote innovation through an interconnected scientific network, fostering collaboration and collective advancement
Scientific Partners
The Penta Foundation is a non-profit organization dedicated to advancing research on pediatric infectious diseases. It serves as a coordinating center for developing, sponsoring, and managing clinical studies and training programs, aiming to improve healthcare outcomes for children worldwide.
Probiomics is an innovative spin-off from the University of Rome Tor Vergata, specializing in the analysis of biological complexity across multiple OMIC levels, including proteomics, RNA sequencing, DNA sequencing, and gene expression in purified cell subsets. Utilizing validated methodologies, the platform offers robust bioinformatics pipelines, deep learning applications, and advanced data interpretation to address complex scientific challenges.
about what we do
At mAIbe we focus on Monoclonal Antibodies against endemic viruses such as HIV and RSV as well as against viruses with pandemic potential.